ロード中...
Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia
Acquired Hemophilia A (AHA) is a rare disease caused by anti-factor VIII autoantibodies. It is usually characterized by clinically significant bleeding at the onset and requires prompt hemostatic and immunosuppressive therapies. Due to its rarity and the lack of randomized trials, its treatment is a...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822901/ https://ncbi.nlm.nih.gov/pubmed/31700733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5630 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|